nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A new era for HIV in the Philippines?
|
Devi, Sharmila |
|
|
405 |
10479 |
p. 611-612 |
artikel |
2 |
A new pathway for primary aldosteronism treatment
|
Leung, Alexander A |
|
|
405 |
10479 |
p. 599-601 |
artikel |
3 |
Angola's cholera outbreak: a wake-up call for global action
|
da Ascensão Gonçalves, Mauer Alexandre |
|
|
405 |
10479 |
p. 620-621 |
artikel |
4 |
B vitamins and the 2024 Lancet Commission on dementia
|
Livingston, Gill |
|
|
405 |
10479 |
p. 623 |
artikel |
5 |
Endoscopic, ultrasound-guided, radiofrequency ablation of aldosterone-producing adenomas (FABULAS): a UK, multicentre, prospective, proof-of-concept trial
|
Argentesi, Giulia |
|
|
405 |
10479 |
p. 637-647 |
artikel |
6 |
Exclusion of street vendors from health insurance
|
Vasudeva, Tanya |
|
|
405 |
10479 |
p. 622 |
artikel |
7 |
Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
|
Vijiaratnam, Nirosen |
|
|
405 |
10479 |
p. 627-636 |
artikel |
8 |
First phase 3 trial of GLP-1 receptor agonist for neurodegeneration
|
Kalia, Lorraine V |
|
|
405 |
10479 |
p. 598-599 |
artikel |
9 |
Gender removal by fiat: impacts of new Trump administration edicts
|
Krieger, Nancy |
|
|
405 |
10479 |
p. 620 |
artikel |
10 |
Gene therapy for the eyes and ears: hopes and challenges
|
The Lancet, |
|
|
405 |
10479 |
p. 597 |
artikel |
11 |
Gene therapy for young children with congenital blindness
|
Cideciyan, Artur V |
|
|
405 |
10479 |
p. 601-603 |
artikel |
12 |
Gene therapy in children with AIPL1-associated severe retinal dystrophy: an open-label, first-in-human interventional study
|
Michaelides, Michel |
|
|
405 |
10479 |
p. 648-657 |
artikel |
13 |
Health-care system adaptability during wildfire disasters: crucial insights from LA County
|
Hertelendy, Attila J |
|
|
405 |
10479 |
p. 621-622 |
artikel |
14 |
Human schistosomiasis
|
Buonfrate, Dora |
|
|
405 |
10479 |
p. 658-670 |
artikel |
15 |
Identifying key randomised clinical trials that could transform clinical care and public health
|
Moorthy, Vasee |
|
|
405 |
10479 |
p. 607-608 |
artikel |
16 |
Medicine and Black politics: Dr J D Harris's remarkable life
|
Willoughby, Christopher D E |
|
|
405 |
10479 |
p. 615-616 |
artikel |
17 |
PEPFAR under review: what's at stake for PEPFAR's future
|
Ratevosian, Jirair |
|
|
405 |
10479 |
p. 603-605 |
artikel |
18 |
Reflections on The Lancet's Commission on dementia prevention, intervention, and care
|
Welberry, Heidi J |
|
|
405 |
10479 |
p. 623-624 |
artikel |
19 |
Reflections on The Lancet's Commission on dementia prevention, intervention, and care
|
Engdahl, Bo |
|
|
405 |
10479 |
p. 624 |
artikel |
20 |
Reflections on The Lancet's Commission on dementia prevention, intervention, and care
|
Benedict, Christian |
|
|
405 |
10479 |
p. 624-625 |
artikel |
21 |
Reflections on The Lancet's Commission on dementia prevention, intervention, and care
|
Qi, Xiang |
|
|
405 |
10479 |
p. 625 |
artikel |
22 |
Reflections on The Lancet's Commission on dementia prevention, intervention, and care – Authors' reply
|
Livingston, Gill |
|
|
405 |
10479 |
p. 625-626 |
artikel |
23 |
Sarah Blagden: designing vaccines for cancer prevention
|
Prasad, Aarathi |
|
|
405 |
10479 |
p. 613 |
artikel |
24 |
Sick city
|
Boyce, Niall |
|
|
405 |
10479 |
p. 614 |
artikel |
25 |
“Silent but deadly”: NCDs in sub-Saharan Africa
|
Thornton, Jacqui |
|
|
405 |
10479 |
p. 609-610 |
artikel |
26 |
Spinal muscular atrophy in the UK: the human toll of slow decisions
|
Servais, Laurent |
|
|
405 |
10479 |
p. 619-620 |
artikel |
27 |
The Lived Experience Academy
|
Gibbs, Christopher |
|
|
405 |
10479 |
p. 617-618 |
artikel |
28 |
The RDI–Lancet Commission on Rare Diseases: improving visibility to address health-care disparities for 400 million people
|
Boycott, Kym M |
|
|
405 |
10479 |
p. 605-607 |
artikel |